This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: deep vein thrombosis

Unlocking the potential of NOACs

December 2014 Br J Cardiol 2014;21(suppl 2):S1–S7

Unlocking the potential of NOACs

Mr Sotiris Antoniou, Dr Chris Arden, Dr Jan Beyer-Westendorf, Dr David Hargroves, Dr Terry McCormack, Professor Gordon McInnes, Dr Raj Patel, Oliver Segal

Abstract

When the NOACs (novel oral anticoagulants) were introduced over three years ago, they promised to revitalise the management of conditions such as atrial fibrillation (AF), venous thromboembolism (VTE) and thromboprophylaxis after major joint replacement surgery. Rivaroxaban is currently available in multiple indications, including (but not limited to): prevention of stroke and systemic embolism in adult patients with non-valvular AF, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and the prevention of recurrent DVT and PE in adults. For decades anticoagulant therapy in these conditions had relied on the vitamin K antagon

| Full text

August 2012 Br J Cardiol 2012;19:107–10

NICE – final guidance on rivaroxaban in DVT

BJCardio Staff

Abstract

Estimates suggest there will be more than 46,000 cases of acute DVT in England and Wales during 2012, which will rise to nearly 50,000 cases by 2016, due in part to the ageing population. Professor Carole Longson, NICE Health Technology Evaluation Centre Director, said: “For many people, using warfarin is difficult because of the need for regular monitoring with blood tests, dosing adjustments, and the need to be careful about their diet because of warfarin’s interaction with certain foods. Because rivaroxaban does not require frequent blood tests to monitor treatment it represents a potential benefit for many people who have had a DVT, p

| Full text
In brief

March 2012 Br J Cardiol 2012;19:12–3

In brief

BJCardio Staff

Abstract

NICE updates A new ‘Evidence Update’ has been produced by the National Institute for Health and Clinical Excellence (NICE), which summarises selected new evidence relevant to the NICE guideline on the management of chronic heart failure (CHF) in adults in primary and secondary care (clinical guideline 108).NICE says “Whilst Evidence Updates do not replace current accredited guidance, they do highlight new evidence that might generate a future changes in practice.”  It says it will welcome feedback from societies and individuals in developing this service. The update is available from www.evidence.nhs.uk/evidence-update-2. New guides

| Full text
Varicose veins, haemorrhoids and the risk of circulatory diseases: record-linkage study

June 2011 Br J Cardiol 2011;18:124–9

Varicose veins, haemorrhoids and the risk of circulatory diseases: record-linkage study

Faisal Rahman, Clare J Wotton, Michael J Goldacre

Abstract

Introduction Varicose veins (VV) are dilated, tortuous, superficial veins found typically in the lower limbs. Haemorrhoids are abnormal distensions of the arteriovenous plexus in enlarged vascular anal cushions, although they are often referred to as varicosities.1 It is unknown whether these two conditions, both classified as disorders of the venous circulatory system,2 are associated with altered risks of other circulatory disorders. If they are, this may suggest clues about shared aetiological mechanisms between VV, haemorrhoids and other circulatory diseases. It would also provide information of prognostic clinical relevance about patien

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now